Acrivon Therapeutics (ACRV) Short-term Investments (2022 - 2026)
Acrivon Therapeutics (ACRV) reported Short-term Investments of $48.54 million for Q2 2026, down 49.2% from $95.53 million a year earlier and down 23.8% from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Short-term Investments (2022 - 2026) Analysis & Trends
At the end of FY2025, Acrivon Therapeutics posted Short-term Investments of $77.08 million, down 44.8% from FY2024.
- Short-term Investments has a three-year compound annual growth rate of -7.8% (FY2022 to FY2025).
- By year, Short-term Investments came in at $139.66 million in FY2024 (+52.7%), $91.44 million in FY2023 (-6.9%) and $98.23 million in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Short-term Investments since Q3 2022.
- Year over year, Short-term Investments has now declined in each of the last five quarters, with an average decline of 11.2% over the last eight quarters.
- The high point for year-over-year Short-term Investments in five years was Q3 2023 (growth of 150.8%); the low point was Q2 2026 (a decline of 49.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $63.67 million (Q1 2026), $77.08 million (Q4 2025) and $93.85 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.91 Bn | 1,109.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 634.46 Bn | 554.32 Bn | 17.30 Bn |
| 3 | AbbVie | 500.42 Bn | 473.54 Bn | 12.70 Bn |
| 4 | Merck | 355.19 Bn | 309.56 Bn | 12.21 Bn |
| 5 | Novartis Ag | 300.18 Bn | 264.17 Bn | 11.24 Bn |
| 6 | Astrazeneca | 263.17 Bn | 236.86 Bn | 12.86 Bn |
| 7 | Amgen | 237.83 Bn | 193.23 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.81 Bn | 168.01 Bn | 6.22 Bn |
| 9 | Pfizer | 170.12 Bn | 116.76 Bn | 10.94 Bn |
| 10 | Acrivon Therapeutics | 71.96 Mn | -363.57 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.54 Mn |
| Mar 31, 2026 | 63.67 Mn |
| Dec 31, 2025 | 77.08 Mn |
| Sep 30, 2025 | 93.85 Mn |
| Jun 30, 2025 | 95.53 Mn |
| Mar 31, 2025 | 110.48 Mn |
| Dec 31, 2024 | 139.66 Mn |
| Sep 30, 2024 | 144.04 Mn |
| Jun 30, 2024 | 134.53 Mn |
| Mar 31, 2024 | 85.37 Mn |
| Dec 31, 2023 | 91.44 Mn |
| Sep 30, 2023 | 112.23 Mn |
| Jun 30, 2023 | 112.88 Mn |
| Mar 31, 2023 | 92.72 Mn |
| Dec 31, 2022 | 98.23 Mn |
| Sep 30, 2022 | 44.74 Mn |
API Access
Acrivon Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();